IRIS
BEDINI, ANNALIDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.867
EU - Europa 5.467
AS - Asia 1.677
Continente sconosciuto - Info sul continente non disponibili 22
SA - Sud America 15
AF - Africa 13
OC - Oceania 10
AN - Antartide 1
Totale 15.072
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.819
GB - Regno Unito 2.069
CN - Cina 1.243
IT - Italia 941
UA - Ucraina 888
SE - Svezia 510
FI - Finlandia 331
TR - Turchia 266
DE - Germania 260
IE - Irlanda 190
FR - Francia 75
IN - India 59
RU - Federazione Russa 54
CA - Canada 46
BE - Belgio 39
KR - Corea 27
NL - Olanda 22
EU - Europa 18
RO - Romania 18
SG - Singapore 17
ES - Italia 15
VN - Vietnam 15
JP - Giappone 14
CH - Svizzera 9
HK - Hong Kong 9
AL - Albania 8
AU - Australia 8
PL - Polonia 8
EG - Egitto 7
BR - Brasile 6
A2 - ???statistics.table.value.countryCode.A2??? 4
IR - Iran 4
PK - Pakistan 4
SI - Slovenia 4
TG - Togo 4
AM - Armenia 3
AT - Austria 3
BD - Bangladesh 3
BG - Bulgaria 3
DK - Danimarca 3
EE - Estonia 3
GR - Grecia 3
HU - Ungheria 3
ID - Indonesia 3
IL - Israele 3
BO - Bolivia 2
GU - Guam 2
IQ - Iraq 2
LU - Lussemburgo 2
PE - Perù 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
FK - Isole Falkland (Malvinas) 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MX - Messico 1
PA - Panama 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 15.072
Salva come PNG Salva come JPEG
Città #
Southend 1.893
Woodbridge 1.169
Fairfield 968
Houston 747
Jacksonville 710
Ann Arbor 677
Chandler 588
Ashburn 453
Cambridge 446
Seattle 376
Wilmington 376
Nanjing 351
Izmir 257
Urbino 244
Dublin 188
Nanchang 152
Helsinki 136
San Mateo 113
Princeton 106
Beijing 97
Shenyang 83
New York 80
Hebei 78
Changsha 73
Tianjin 71
Düsseldorf 70
Jiaxing 52
Boardman 48
Kunming 43
Des Moines 41
Brussels 38
Jinan 38
Velikiy Novgorod 38
Bremen 35
Venice 30
Toronto 28
San Diego 27
Hangzhou 26
San Francisco 26
London 24
Seongnam 24
Zhengzhou 23
Ningbo 22
Mülheim 20
Haikou 19
Wuppertal 18
Los Angeles 17
Shanghai 17
Tavullia 17
Changchun 15
Milan 15
Parma 15
Bologna 14
Guangzhou 14
Lanzhou 14
Norwalk 13
Rome 12
Auburn Hills 11
Augusta 11
Monte Porzio 11
Dong Ket 10
Leawood 10
Mcallen 10
Redwood City 10
Taizhou 10
Dearborn 9
Munich 9
Orange 9
Frankfurt am Main 8
Scottsdale 8
West Jordan 8
Acquasanta Terme 7
Ascoli Piceno 7
Portland 7
Prescot 7
Tirana 7
Acton 6
Focsani 6
Fuzhou 6
Madrid 6
Singapore 6
Timisoara 6
Borås 5
Fano 5
Jesi 5
Kiev 5
Kilburn 5
Macerata 5
Monmouth Junction 5
Mumbai 5
Naples 5
Osimo 5
Ancona 4
Angri 4
Calgary 4
Chieti 4
Dormagen 4
Florence 4
Hanoi 4
Lomé 4
Totale 11.572
Salva come PNG Salva come JPEG
Nome #
Iridium-Catalyzed Direct Synthesis of Tryptamine Derivatives from Indoles: Exploiting N-Protected β-Amino Alcohols as Alkylating Agents 309
1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID DERIVATIVES AS LIGANDS AT THE GLYCINE-BINDING SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR 302
1-Aminocyclopropane-1-carboxylic acid derivatives as ligands at the glicine-site of the NMDA receptor. 284
1-Aminocyclopropane-1-carboxylic acid derivatives: Synthesis and NMDA receptor complex binding affinity study. 248
Synthesis of Tryptamine Derivatives via a Direct, One-Pot Reductive Alkylation of Indoles 237
Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties 229
Tricyclic Alkylamides as Melatonin Receptor Ligands with Antagonist or Inverse Agonist Activity 222
An improved synthesis of cis-4-phenyl-2-propionamidotetralin (4-P-PDOT): a selective MT2 melatonin receptor antagonist. 221
Therapeutic uses of melatonin and melatonin derivatives: a patent review (2012-2014) 220
1-Amminocyclopropane-1-Carboxylic Acid Derivatives: A New, General Synthesis and NMDA Receptor Complex Binding Affiniy Study 219
Antidepressant-like activity and cardioprotective effects of fatty acid amide hydrolase inhibitor URB694 in socially stressed Wistar Kyoto rats 219
Direct, One-Pot Reductive Alkylation of Anilines with Functionalized Acetals Mediated by Triethylsilane and TFA. Straightforward Route for Unsymmetrically Substituted Ethylenediamine 218
Synthesis and Configuration Determination of All Enantiopure Stereoisomers of the Melatonin Receptor Ligand 4-Phenyl-2-propionamidotetralin using an Expedient Optical Resolution of 4-Phenyl-2-tetralone 212
Synthesis and Characterization of New Bivalent Agents as Melatonin- and Histamine H3-Ligands 206
Synthesis and Biological Activity of new melatonin dimeric derivatives. 205
Tetrahydroquinoline Ring as a Versatile Bioisostere of Tetralin for Melatonin Receptor Ligands 201
(E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists. 196
Design, synthesis and biological activity of hydrogen peroxide responsive arylboronate melatonin hybrids 190
4,5-Dihydroisoxazole and 4,5-dihydro-1,2,4-oxadiazole derivatives from cycloaddition reactions of nitrile oxides to alkyl N-(diphenylmethylene)-α ,β -dehydroamino acids 189
An improved route to cycloalka[b]pyrrole 2-carboxylates 186
3-(2-Carbamoylvinyl)-4,5-dimethylpyrrole-2-carboxylic acids as ligands at the NMDA glycine-binding site: a study on the 2-carbamoylvinyl chain modification 184
Synthetic Melatonin Receptor Ligands 184
Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines 184
The rationale for the development of melatonin receptor ligands 182
Toward the Definition of Stereochemical Requirements for MT(2)-Selective Antagonists and Partial Agonists by Studying 4-Phenyl-2-propionamidotetralin Derivatives 182
N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands. 179
Differentiation between isomeric 1-aminocyclopropane-1-carboxylic acid derivatives by means of chemical ionisation and mass selected collision induced dissociation 174
Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy 174
Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety 173
Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand 172
Plant-derived phenolic compounds prevent the DNA single-strand breakage and cytotoxicity induced by tert-butylhydroperoxide via an iron-chelating mechanism. 171
Synthesis, Enantiomeric Resolution and Structure-Activity Relationship Study for a Series of 10,11-Dihydro-5H-dibenzo[a,d]cycloheptene MT2 Receptor Antagonists. 167
MELATONIN RECEPTOR AGONISTS: SAR AND APPLICATIONS TO THE TREATMENT OF SLEEP-WAKE DISORDERS 164
Substituent effects on 1,3-dipolar cycloadditions to some 1,1-diphenyl-2-aza-1,3-butadiene derivatives 164
Identification of Bivalent Ligands with Melatonin Receptor Agonist and Fatty Acid Amide Hydrolase (FAAH) Inhibitory Activity That Exhibit Ocular Hypotensive Effect in the Rabbit 163
Diastereo- and enantioselective hydrogenation of a challenging enamide derived from 4-phenyl-2-tetralone: an appealing shortcut towards enantiopure cis-2-aminotetraline derivatives 162
Melatonin MT1 and MT2 Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle 162
Application of 3D-QSAR in the Rational Design of Receptor Ligands and Enzyme Inhibitors 160
Selective Melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways 155
Design and synthesis of N-[3,3-diphenyl-propenyl]alkanamides as a novel class of potent MT2-selective Melatonin receptor ligands 152
Bivalent Ligand Approach on N-[2-[(3-methoxyphenyl)methylamino]ethyl]acetamide. Synthesis, Binding Affinity and Intrinsic Acivity for MT(1) and MT(2) melatonin Receptors. 152
2,3-Dehydroamino acid derivatives as intermediates in the synthesis of heterocyclic compounds. 150
Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells 150
Recent advances in the development of melatonin MT1 and MT2 receptor agonists 148
Synthesis and conformational study of 3,4-carbocyclic bridged indole melatonin and serotonin analogues 147
2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists 146
Homology models of melatonin receptors: challenges and recent advances 145
THREE-DIMENSIONAL QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP STUDIES ON SELECTED MT1 AND MT2 MELATONIN RECEPTOR LIGANDS: REQUIREMENTS FOR SUBTYPE SELECTIVITY AND INTRINSIC ACTIVITY MODULATION 143
N-Acyl-5- and -2,5-substituted tryptamines: synthesis, activity and affinity for human mt1 and MT2 melatonin receptors 143
Reactions of 3-Carbomethoxy-2-aza-1,3-Butadiene Derivatives with Dienophiles 143
Alchilammidi tricicliche: legandi selettivi dei recettori melatoninergici MT1 e MT2 143
Strategies leading to MT2 selective melatonin receptor antagonists 142
Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765: Comparison with melatonin and diazepam 142
Application of a non-electrophysiological method to study binding affinity and efficacy of glicine analogs to the glicine site of the NMDA receptor-ion channel complex. 141
Strategies leading to MT2 selective melatonin receptor antagonists 141
N-acetiltriptamine 2,5-sostituite: sintesi e valutazione dell’attività biologica per i recettori melatoninergici MT1 e MT2 140
Melatonin receptor agonists: new options for insomnia and depression treatment 140
N-(Substituted-anilinoethyl)acylamides: Design, Synthesis and Pharmacological Characterization of a New Class of Melatonin Receptor Ligands 138
Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models 138
(E)-3-[2-(Carbamoylvinyl)]pyrrol-2-carboxylic acid derivatives: A novel Class of glycine site Antagonists. 134
Short synthesis of tryptophan and β -carboline derivatives by reaction of indoles with N-(diphenylmethylene)-α ,β -didehydroamino acid esters 131
Progettazione e Sintesi di nuovi ligandi dei recettori MT1 e MT2 della melatonina a struttura difenilalchilammidica. 131
Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity 131
Synthesis and biological evaluation of 6-bromo-6-substituted penicillanic acid derivatives as beta-lactamase inhibitors. 125
Melatonin, non-selective MT1/MT2 and selective MT2 receptor agonists: differential effects on the 24-hr vigilance states 125
Synthesis, Pharmacological Characterization and QSAR Studies on 2-Substituted Indole Melatonin Receptor Ligands 125
Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities 124
SYNTHESIS, BINDING AFFINITY FOR THE MELATONIN RECEPTOR, AND EVALUATION OF THE BIOLOGICAL ACTIVITY OF NEW INDOLE-BASED MELATONIN ANALOGUES. 123
Towards the development of mixed MT1-agonist/MT2-antagonist melatonin receptor ligands 121
MT2 selective melatonin receptor antagonists. Design and structure activity relationships 119
ANTIMETASTATIC ACTION OF A NEW ANALOG OF DACARBAZINE IN MICE BEARING LEWIS LUNG CARCINOMA 118
N-(anilinoethyl)acylamides: new melatonin receptor ligands with sleep inducing properties. 116
MT2 selective melatonin receptor antagonists: design and structure-activity relationships 112
A novel melatonin partial agonist with sleep-promoting properties 111
Synthesis of new 6-bromopenicillanic acid derivatives as potential β-lactamase inhibitors. 110
Antioxidant and cytoprotective activity of indole derivatives related to melatonin, 109
Correlation of the antimetastatic properties of aryltriazenes with their Electron Impact Ionization Mass Spectronomy 108
MT1-Selective Melatonin Receptor Ligands: Synthesis, Pharmacological Evaluation, and Molecular Dynamics Investigation of N-{[(3-O-Substituted)anilino]alkyl}amides 104
Synthesis of new C-6 alkylidene penicillin derivatives as beta-lactamase inhibitors 101
In vitro metabolism of the melatonin MT2-receptor selective ligand UCM765 by rat, mouse and human liver substrates 100
Synthesis, binding and QSAR studies of new 2-substituted melatonergic agonists. 99
INVESTIGATION OF SOME 2,3-DIDEHYDRO AMINOACIFS BY FAST ATOM BOMBARDMENT, CHEMICAL IONIZATION AND MASS-SELECTED COLLISION-INDUCED DISSOCIATION MASS SPECTROMETRY. 99
Analoghi della melatonina: effetto dei sostituenti sull’attività di derivati N-acetiltriptaminici. 98
A novel melatonin partial agonist with sleep promoting properties and anti-anxiety effects. 98
Selective increase of Slow Wave Sleep (SWS) by a novel melatonin partial agonist 98
Rapid and transient stimulation of intracellular reactive oxygen species by melatonin in normal tumor leukocytes, Toxicology and apllied Pharmacology, 239(1), 37-45 (2009) 95
Synthesis of new 6-alkyliden penicillin derivatives as potential beta-lactamase inhibitors. 93
Selective increase of Slow Wave Sleep (SWS) by melatonin 2 receptors. 90
A novel melatonin partial agonist with sleep-promoting properties. 89
Novel melatonin ligands having antidepressant activity as well as sleep inducine properties 84
2-5-Disubstituted tryptamines a selective serotonin 5HT6 receptor agonists. 84
Design and structure-activity relationships of subtype selective melatonin receptor ligands. 83
STRUCTURAL CHARACTERIZATION OF ISOMERIC DIDEHYDRO AMINOACIDS USING CHEMIAL IONIZATION 82
Antioxidant and cytoprotective effect of indole derivatives related to melatonin 81
Relazioni struttura attività per analoghi indolici della melatonina ad azione antiossidante e citoprotettiva 77
In vitro evaluation of antioxidant activity for a series of 2-acylaminoethylindoles, PBA2004 76
Design and synthesis of metabolically protected melatonin receptor agonists 73
2-Arylmelatonin analogues: Probing the 2-phenyl binding pocket of melatonin MT1 and MT2 receptors 72
Razionalizzazione dell’attività di antagonisti MT2 selettivi mediante docking e dinamica molecolare in modelli dei recettori MT1 e MT2 della melatonina. 71
Novel anti-anxiety and sleep-promoting melatonin receptor ligands from modulation of N-anilinoethylamide structure. 70
Totale 14.843
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.474
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019847 0 0 0 0 0 0 0 0 0 0 247 600
2019/20203.369 670 136 229 770 154 278 283 258 169 211 87 124
2020/20211.989 61 137 81 267 108 135 119 156 326 225 255 119
2021/20221.284 128 145 125 165 23 35 57 62 86 72 31 355
2022/20231.850 209 122 56 207 163 405 7 165 296 56 122 42
2023/2024504 32 58 28 77 40 100 32 13 67 57 0 0
Totale 15.315